This is out Library. Please click on the article title to view the details.
submitted by: admin on 05/19/2015
Experts published in the British Medical Journal that there's serious doubt that the use of drugs to prevent diseases such as high cholesterol, osteoporosis and osteopenia, and hypertension are cost effective. In the case of Lipitor, it costs approximately $600,000 to prevent a single heart attack and still not save a single life when used for primary prevention....
submitted by: admin on 10/26/2015
Low dose aspirin can lower the risk of heart attacks in people without a history of heart disease by about 20%, but it does not lower the death rate or the risk of stroke. Also, there is the added risk of GI bleeding secondary to aspirin use. The risk for getting a heart attack in primary prevention is lowered from 2.3% to 1.8%, which comes to a 20% lower risk...
submitted by: admin on 09/24/2013
A meta-analysis showed that high dose statin therapy as primary prevention caused an increased risk for type 2 diabetes. The article published in JAMA goes on to say that treatment of 32,000 non-diabetics with 5 years high dose statin treatment caused 149 more cases of type 2 diabetes, but 416 fewer cardiovascular events.This is a very misleading journal article...
submitted by: admin on 04/12/2015
For primary prevention of heart attacks there's no data showing that there's an increase in survival. And there are many side effects of statins that are problematic such as liver inflammation, peripheral neuropathy, muscle inflammation, type 2 diabetes, kidney failure, global amnesia. Lifestyle is still the major way to stop and reverse heart...